ShowcasesPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$106.9B
P/E ratio
27x
Income statementBalance sheetCash flowOther
Raw aggregated data